Estrogen receptors inhibit Smad3 transcriptional activity through Ap-1 transcription factors

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Molecular and Cellular Biochemistry

• Publication date

  2007-07-28

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11010-007-9551-1PMID 17660955
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Estrogen receptor (ER)-beta isoforms: a key to understanding ER-beta signaling.

  2006cited by this paper
• Estrogen receptor (ER)-β isoforms: A key to understanding ER-β signaling

  2006cited by this paper
• Expression of oestrogen receptor-β in oestrogen receptor-α negative human breast tumours

  2006cited by this paper
• 17-β-estradiol inhibits transforming-growth-factor-β-induced MCF-7 cell migration by Smad3-repression

  2006cited by this paper
• STEROIDRECEPTORSANDPROLIFERATIONIN THE HUMANBREAST Results and Discussion Distribution of ER in Normal Human Breast Lobules

  2006cited by this paper
• 17-Beta-estradiol inhibits transforming-growth-factor-beta-induced MCF-7 cell migration by Smad3-repression.

  2006cited by this paper
• The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: role of p300/CBP

  2005cited by this paper
• Antiestrogens induce growth inhibition by sequential activation of p38 mitogen-activated protein kinase and transforming growth factor-beta pathways in human breast cancer cells.

  2004cited by this paper
• Transfection of adherent and suspended cells by calcium phosphate.

  2004cited by this paper
• Estrogen Receptor Inhibits c-Jun-dependent Stress-induced Cell Death by Binding and Modifying c-Jun Activity in Human Breast Cancer Cells*

  2004cited by this paper
• Putative functional characteristics of human estrogen receptor-beta isoforms.

  2003cited by this paper
• An activator protein 1-like motif mediates 17beta-estradiol repression of gonadotropin-releasing hormone receptor promoter via an estrogen receptor alpha-dependent mechanism in ovarian and breast cancer cells.

  2003cited by this paper
• AP-1: a double-edged sword in tumorigenesis

  2003cited by this paper
• The effect of antiestrogens on TGF-beta-mediated chemotaxis of human breast cancer cells.

  2002cited by this paper
• Cross-talk between bone morphogenic proteins and estrogen receptor signaling.

  2002cited by this paper
• Relationship of coregulator and oestrogen receptor isoform expression to de novo tamoxifen resistance in human breast cancer

  2002cited by this paper
• ERβ1 and the ERβ2 Splice Variant (ERβcx/β2) Are Expressed in Distinct Cell Populations in the Adult Human Testis

  2002cited by this paper
• Expression of Estrogen Receptor (ER) βcx Protein in ERα-positive Breast Cancer: Specific Correlation with Progesterone Receptor

  2002cited by this paper
• Alterations of Smad signaling in human breast carcinoma are associated with poor outcome: a tissue microarray study.

  2002cited by this paper
• ERbeta1 and the ERbeta2 splice variant (ERbetacx/beta2) are expressed in distinct cell populations in the adult human testis.

  2002cited by this paper
• The Androgen Receptor Represses Transforming Growth Factor-β Signaling through Interaction with Smad3*

  2002cited by this paper
• Expression of estrogen receptor (ER) (beta)cx protein in ER(alpha)-positive breast cancer: specific correlation with progesterone receptor.

  2002cited by this paper
• Steroid receptors in human breast tumorigenesis and breast cancer progression.

  2002cited by this paper
• From transforming growth factor-β signaling to androgen action: Identification of Smad3 as an androgen receptor coregulator in prostate cancer cells

  2001cited by this paper
• Smad3/AP-1 interactions control transcriptional responses to TGF-β in a promoter-specific manner

  2001cited by this paper
• Cross-talk between Transforming Growth Factor-β and Estrogen Receptor Signaling through Smad3*

  2001influential reference
• Characterization of the physical interaction between estrogen receptor alpha and JUN proteins.

  2001cited by this paper
• From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.

  2001cited by this paper
• BRCA1 mediates ligand-independent transcriptional repression of the estrogen receptor

  2001cited by this paper
• Estrogen Receptor Binding to DNA Is Not Required for Its Activity through the Nonclassical AP1 Pathway*

  2001cited by this paper
• SMAD3 represses androgen receptor-mediated transcription.

  2001cited by this paper
• Characterization of the Physical Interaction between Estrogen Receptor α and JUN Proteins*

  2001cited by this paper
• Altered expression of estrogen receptor coregulators during human breast tumorigenesis.

  2000cited by this paper
• p300 Mediates Functional Synergism between AF-1 and AF-2 of Estrogen Receptor α and β by Interacting Directly with the N-terminal A/B Domains*

  2000cited by this paper
• Critical Role of Smads and AP-1 Complex in Transforming Growth Factor-β-dependent Apoptosis*

  2000cited by this paper
• Nuclear receptor coregulators: cellular and molecular biology.

  1999influential reference
• Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators.

  1999influential reference
• Glucocorticoid receptor inhibits transforming growth factor-beta signaling by directly targeting the transcriptional activation function of Smad3.

  1999cited by this paper
• Expression of estrogen receptor beta1, beta2, and beta5 messenger RNAs in human breast tissue.

  1999cited by this paper
• Positive and Negative Modulation of Vitamin D Receptor Function by Transforming Growth Factor-β Signaling through Smad Proteins*

  1999cited by this paper
• Smads bind directly to the Jun family of AP-1 transcription factors.

  1999cited by this paper
• Molecular cloning and characterization of human estrogen receptor betacx: a potential inhibitor ofestrogen action in human.

  1998cited by this paper
• The Role of Mammary Stroma in Modulating the Proliferative Response to Ovarian Hormones in the Normal Mammary Gland

  1998cited by this paper
• Molecular cloning and characterization of human estrogen receptor βcx: A potential inhibitor of estrogen action in human

  1998cited by this paper
• Physical and Functional Interaction of SMADs and p300/CBP*

  1998cited by this paper
• Transforming growth factor-beta in breast cancer: a working hypothesis.

  1997cited by this paper
• Tumor suppressor Smad4 is a transforming growth factor beta-inducible DNA binding protein

  1997cited by this paper
• Estrogen Receptors α and β Form Heterodimers on DNA*

  1997cited by this paper
• Transforming growth factor-β in breast cancer: A working hypothesis

  1997cited by this paper
• Role of TGF beta in the anti-estrogen response/resistance of human breast cancer.

  1996cited by this paper
• Role of TGFβ in the anti-estrogen response/resistance of human breast cancer

  1996cited by this paper
• Tamoxifen induces TGF‐β1 activity and apoptosis of human MCF‐7 breast cancer cells in vitro

  1996cited by this paper
• Complex role of tumor cell transforming growth factor (TGF)-βs on breast carcinoma progression

  1996cited by this paper
• Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens.

  1995cited by this paper
• Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer.

  1992cited by this paper
• Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast.

  1992cited by this paper
• Transforming growth factor beta 1 is implicated in the failure of tamoxifen therapy in human breast cancer.

  1991cited by this paper
• Effects of TGFβ on Normal and Malignant Mammary Epithelium

  1990cited by this paper
• Effects of TGF beta on normal and malignant mammary epithelium.

  1990cited by this paper

• Nutraceutical and Dietary Measures with Potential for Preventing/Controlling Non-Alcoholic Fatty Liver Disease and Its Complications

  2024cites this paper
• Transcriptional responses to direct and indirect TGFB1 stimulation in cancerous and noncancerous mammary epithelial cells

  2024cites this paper
• Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies.

  2024cites this paper
• Sex-biased TGFβ signalling in pulmonary arterial hypertension

  2023cites this paper
• TGFβ1 pathway components in breast cancer tissue from aggressive subtypes correlate with better prognostic parameters in ER-positive and p53-negative cancers

  2021cites this paper
• Implications of TGFβ Signaling and CDK Inhibition for the Treatment of Breast Cancer

  2021cites this paper
• Role of TGF-β signaling in the mechanisms of tamoxifen resistance.

  2021cites this paper
• A nutraceutical strategy for downregulating TGFβ signalling: prospects for prevention of fibrotic disorders, including post-COVID-19 pulmonary fibrosis

  2021cites this paper
• A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue

  2019cites this paper
• Regulation of Telomerase Activity

  2018cites this paper
• Estrogen receptor α- (ERα), but not ERβ-signaling, is crucially involved in mechanostimulation of bone fracture healing by whole-body vibration.

  2018cites this paper
• First trimester human placenta prevents breast cancer cell attachment to the matrix: The role of extracellular matrix

  2017cites this paper
• Association between Single Nucleotide Polymorphisms of SMAD3 and BMP5 with the Risk of Knee Osteoarthritis.

  2017cites this paper
• Estrogen modulates mesenchyme-epidermis interactions in the adult nipple

  2017cites this paper
• The role of TGF-&bgr; in the pathophysiology of peritoneal endometriosis

  2017cites this paper
• Down-regulation of hTERT and Cyclin D1 transcription via PI3K/Akt and TGF-β pathways in MCF-7 Cancer cells with PX-866 and Raloxifene.

  2016influential citation
• Combinatorial PX‐866 and Raloxifene Decrease Rb Phosphorylation, Cyclin E2 Transcription, and Proliferation of MCF‐7 Breast Cancer Cells

  2016cites this paper
• Tamoxifen Inhibits TGF‐β‐Mediated Activation of Myofibroblasts by Blocking Non‐Smad Signaling Through ERK1/2

  2015cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2014cites this paper
• Control of transcriptional repression of the vitellogenin receptor gene in largemouth bass (Micropterus salmoides) by select estrogen receptors isotypes.

  2014cites this paper
• Cellular and humoral immunodeficiency in breast cancer patients resistant to hormone therapy.

  2014cites this paper
• Effects of 4-nonylphenol and bisphenol A on stimulation of cell growth via disruption of the transforming growth factor-β signaling pathway in ovarian cancer models.

  2014cites this paper
• RETRACTED ARTICLE: Regulation of estrogen receptor signaling in breast carcinogenesis and breast cancer therapy

  2013cites this paper
• Regulation of the human catalytic subunit of telomerase (hTERT).

  2012influential citation
• Three Nuclear Receptors Involved in Gender-Related Proliferative Diseases (ER-β LXR-α, and LXR-β)

  2012cites this paper
• A DNA Repair BRCA1 Estrogen Receptor and Targeted Therapy in Breast Cancer

  2012cites this paper
• Estrogens and progression of diabetic kidney damage.

  2011cites this paper
• The influence of progesterone and 17β-estradiol on the activity of peripheral blood mononuclear cells

  2011cites this paper
• Crosstalk of TGF-β and Estrogen Receptor Signaling in Breast Cancer

  2011cites this paper
• Estrogen Inhibits Transforming Growth Factor β Signaling by Promoting Smad2/3 Degradation*

  2010cites this paper
• Einfluss von FTY720, S1P und Estrogen auf die Tumorpromotion

  2010cites this paper
• Role of TGF-betas in normal human endometrium and endometriosis.

  2010cites this paper
• Genetic variation in the SMAD3 gene is associated with hip and knee osteoarthritis.

  2010cites this paper
• Cellular targets of estrogen signaling in regeneration of inner ear sensory epithelia.

  2009cites this paper
• Dual mechanism of deltaEF1 expression regulated by bone morphogenetic protein-6 in breast cancer.

  2009cites this paper
• Cis-regulatory Sequence and Co-regulatory Transcription Factor Functions in ERα-Mediated Transcriptional Repression

  2009cites this paper
• 17-β-Estradiol Inhibits Transforming Growth Factor-β Signaling and Function in Breast Cancer Cells via Activation of Extracellular Signal-Regulated Kinase through the G Protein-Coupled Receptor 30

  2008cites this paper